Harvard Bioscience Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | Outperform |
10
|
$585.03 | Buy/Sell | $591.94 | 5.98% | 1 | $223.32B |
| DHR | Danaher | Outperform |
10
|
$261.40 | Buy/Sell | $260.33 | 4.22% | 4 | $193.62B |
| BDX | Becton Dickinson and Co | Outperform |
9
|
$230.35 | Buy/Sell | $284.47 | 21.55% | 8 | $66.57B |
| LONN | Lonza Group | Buy |
16
|
CHF512.00 | Buy/Sell | CHF516.89 | 17.19% | 8 | CHF36.92B |
| BIO | Bio-Rad Laboratories Inc | Outperform |
16
|
$290.25 | Buy/Sell | $536.80 | 42.64% | 1 | $7.92B |
| MXCT | MaxCyte | Buy |
8
|
£3.67 | Buy/Sell | £9.66 | 89.10% | 6 | £303.18M |